News
Discover the official launch of Arialief in United States, UK, NZ, Canada and Australia, a new supplement developed to ...
Experts now better understand the causes of different types of chronic pain. Here's what to know about the treatments that ...
Topical Ketamir-2 significantly reduced both acute and inflammatory pain behaviors in animals, demonstrating rapid onset, ...
Among patients with T2D and DPN, some with nonpainful DPN developed neuropathic pain over a 5-year period while others with painful DPN experienced relief.
There's a treatment helping chronic pain patients by disrupting pain signals in the body from getting to the brain.
Oral, non-opioid drug candidate advancing through Phase 1 and nearing completion of the single ascending dose (SAD) portion ...
The experimental drug is similar to the Boston-based company’s recently approved pill Journavx but could potentially be given ...
Inspired by the success of Audifort Drops, Audizen Drops are now officially launched in the United States, UK, NZ, Canada, ...
12h
TipRanks on MSNMira announces acceptance of second Ketamir-2 manuscript for publication
MIRA Pharmaceuticals (MIRA) announced the acceptance of a second peer-reviewed manuscript describing its lead oral drug candidate, Ketamir-2, in ...
If caught an an early stage, kidney disease can be easily handled. Early kidney disease is sometimes tricky to diagnose, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results